androgenetic alopecia
Showing 1 - 25 of 108
Androgenetic Alopecia Trial in New City (NTAP)
Active, not recruiting
- Androgenetic Alopecia
- NTAP
-
New City, New YorkThe Skin Center Dermatology Group
Nov 20, 2023
Androgenetic Alopecia Trial in China (KX-826-(5%) BID, Placebo)
Active, not recruiting
- Androgenetic Alopecia
- KX-826-(5%) BID
- Placebo
-
Hefei, Anhui, China
- +25 more
Nov 6, 2023
Androgenetic Alopecia Trial in Beijing (-Q2W, HMI-115-120mg-Q4W, HMI-115-240mg-Q4W)
Recruiting
- Androgenetic Alopecia
- placebo-Q2W
- +3 more
-
Beijing, Beijing, ChinaPeking University People's Hospital
Nov 3, 2023
Androgenetic Alopecia Trial in Jakarta Pusat (drug, other, combination product)
Active, not recruiting
- Androgenetic Alopecia
- Minoxidil Topical
- +2 more
-
Jakarta Pusat, DKI Jakarta, Indonesia
- +1 more
Oct 5, 2023
Androgenetic Alopecia Trial in Jakarta Pusat (Platelet-Rich Plasma and Topical 5% Minoxidil, Topical 5% Minoxidil)
Active, not recruiting
- Androgenetic Alopecia
- Platelet-Rich Plasma and Topical 5% Minoxidil
- Topical 5% Minoxidil
-
Jakarta Pusat, Greater Jakarta Area, IndonesiaDr. Cipto Mangunkusumo National General Hospital
Sep 12, 2023
Androgenetic Alopecia Trial in Jakarta (Finasteride, Minoxidil)
Recruiting
- Androgenetic Alopecia
-
Jakarta, Other (Non U.s.), IndonesiaUniversity Indonesia
Aug 4, 2023
Androgenetic Alopecia Trial in Jakarta (Minoxidil 5% Topical Solution, microneedling)
Recruiting
- Androgenetic Alopecia
- Minoxidil 5% Topical Solution
- microneedling
-
Jakarta, DKI Jakarta, IndonesiaCipto Mangungkusumo Hospital
Aug 3, 2023
Male Pattern Baldness, Androgenetic Alopecia, Hair Loss/Baldness Trial in Ankara, Istanbul (SAGA-001 (A), SAGA-001 (B))
Recruiting
- Male Pattern Baldness
- +4 more
- SAGA-001 (A)
- SAGA-001 (B)
-
Ankara, Turkey
- +1 more
Aug 4, 2023
Androgenetic Alopecia, Female Pattern Baldness Trial (Minoxidil Tablets, Minoxidil Topical, Placebo oral tablet)
Not yet recruiting
- Androgenetic Alopecia
- Female Pattern Baldness
- Minoxidil Tablets
- +3 more
- (no location specified)
Jun 2, 2023
Androgenetic Alopecia Trial in Gyeonggi-do (CKD-498 dose#1, CKD-498 dose#2, CKD-498 dose#3)
Recruiting
- Androgenetic Alopecia
- CKD-498 dose#1
- +5 more
-
Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Jan 10, 2023
Androgenetic Alopecia Trial in East Melbourne, Pascoe Vale South (prostaglandin F2a analogue in vehicle solution high dose,
Recruiting
- Androgenetic Alopecia
- prostaglandin F2a analogue in vehicle solution high dose
- +3 more
-
East Melbourne, Victoria, Australia
- +1 more
Dec 20, 2022
Androgenetic Alopecia Trial (Finlândia Association + finasteride , Minoxidil + finasteride)
Not yet recruiting
- Androgenetic Alopecia
- Finlândia Association + finasteride placebo
- Minoxidil + finasteride
- (no location specified)
Aug 3, 2022
Scarring Alopecia, Androgenetic Alopecia Trial (Sciton HALO 1470nm Non-ablative laser)
Not yet recruiting
- Scarring Alopecia
- Androgenetic Alopecia
- Sciton HALO 1470nm Non-ablative laser
- (no location specified)
Jul 13, 2022
Androgenetic Alopecia Trial in Edina (incobotulinumtoxin A)
Not yet recruiting
- Androgenetic Alopecia
- incobotulinumtoxin A
- (no location specified)
Jul 7, 2022
Acne Vulgaris, Androgenetic Alopecia Trial in San Diego, Salt Lake City (GT20029 Gel, GT20029 Gel Placebo)
Recruiting
- Acne Vulgaris
- Androgenetic Alopecia
- GT20029 Gel
- GT20029 Gel Placebo
-
San Diego, California
- +1 more
Jun 16, 2022
PAI-1 Expression in Non-scarring Hair Loss
Terminated
- Androgenetic Alopecia
- +2 more
-
Chicago, IllinoisNorthwestern University Department of Dermatology
Jun 7, 2022
Androgenetic Alopecia Trial in Burlington (Autologous platelet-rich plasma)
Recruiting
- Androgenetic Alopecia
- Autologous platelet-rich plasma
-
Burlington, MassachusettsLahey Hospital and Medical Center
May 18, 2022
Androgenetic Alopecia Trial (LaserCap SD, Sham LaserCap, LaserCap HD+)
Not yet recruiting
- Androgenetic Alopecia
- LaserCap SD
- +2 more
- (no location specified)
May 4, 2022
Androgenetic Alopecia Trial in Cleveland (Minoxidil, Placebo)
Completed
- Androgenetic Alopecia
- Minoxidil
- Placebo
-
Cleveland, OhioSkin Study Center, UH Case Medical Center
Apr 28, 2022
Androgenetic Alopecia Trial in Melbourne E. (HMI-115)
Not yet recruiting
- Androgenetic Alopecia
-
Melbourne E., Victoria, AustraliaDr Rodney Sinclair Pty Ltd, trading as Sinclair Dermatology
Apr 11, 2022
Androgenetic Alopecia Trial in Cairo (Topical cetirizine, Placebo, Topical minoxidil)
Active, not recruiting
- Androgenetic Alopecia
- Topical cetirizine
- +2 more
-
Cairo, ِAl-Kasr Al-Ainy, EgyptAl-Kasr Al-Ainy outpatient dermatology clinic
Feb 21, 2022
Androgenetic Alopecia Trial in Brisbane (Finasteride 1mg Tablet, IVL3001)
Completed
- Androgenetic Alopecia
- Finasteride 1mg Tablet
- IVL3001
-
Brisbane, AustraliaNucleus Network
Feb 16, 2022
In-vitro Diagnostic Test to Predict COVID-19 Mortality and
Recruiting
- SARS-CoV 2
- +5 more
- CAG length <22
- CAG length >=22
-
Madrid, SpainHospital Universitario Ramon y Cajal
Feb 17, 2022
Androgenetic Alopecia Trial (MK0906, finasteride / Duration of Treatment : 48 Weeks, Comparator : (unspecified) / Duration of
Completed
- Androgenetic Alopecia
- MK0906, finasteride / Duration of Treatment : 48 Weeks
- Comparator : placebo (unspecified) / Duration of Treatment : 48 Weeks
- (no location specified)
Feb 7, 2022